Mannose binding lectin and prediction of risk for chemotherapy induced febrile neutropenia in patients with a solid tumor

被引：1

作者：

Epskamp, Cynthia ^{[1
]}

Goudzwaard, Jeannette A. ^{[2
]}

Fiets, Edward ^{[3
]}

Zuetenhorst, Johanna M. ^{[1
]}

Polee, Marco B. ^{[3
]}

van de Geijn, Gert-Jan M. ^{[4
]}

van Schaik, Ron H. N. ^{[2
]}

Birnie, Erwin ^{[5
]}

Hamberg, Paul ^{[1
]}

机构：

[1] Franciscus Gasthuis, Dept Internal Med, Postbus 10900, NL-3004 BA Rotterdam, Netherlands

[2] Erasmus MC, Dept Internal Med, Rotterdam, Netherlands

[3] Med Ctr Leeuwarden, Dept Internal Med, Leeuwarden, Netherlands

[4] Franciscus Gasthuis, Dept Clin Chem, Rotterdam, Netherlands

[5] Franciscus Gasthuis, Dept Stat & Educ, Rotterdam, Netherlands

来源：

CANCER INVESTIGATION | 2019年 / 37卷 / 03期

关键词：

Mannose-binding lectin (MBL); Solid tumors; Febrile neutropenia; MBL-; genotype; MBL-deficiency; GENE POLYMORPHISMS; SEVERE INFECTIONS; MBL; ASSOCIATION; DEFICIENCY; FICOLINS;

D O I：

10.1080/07357907.2019.1582660

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

Mannose-binding lectin (MBL) - deficient patients who undergo chemotherapy for a solid tumor might have an increased risk developing febrile neutropenia (FN). We investigated in a prospective cohort study relations between MBL-serum levels and polymorphisms in MBL promotor genotypes (-550H/L and -221X/Y) on incidence and severity of FN. Risk of FN was 17.9% in MBL-deficient and 22.5% in MBL-sufficient patients (RR=0.796, p=0.45). Median MBL serum levels at baseline were respectively 1.39 mu g/mL and 1.09 mu g/mL (p=0.92) in patients with and without FN. In conclusion, serum MBL and MBL genotypes (-550H/L and -221X/Y) do not determine the risk for developing FN.

引用

页码：156 / 162

页数：7

共 50 条

[1] Mannose-Binding Lectin (MBL) and the Risk for Febrile Neutropenia and Infection in Pediatric Oncology Patients With Chemotherapy
Frakking, F. N. J.
Israels, J.
Kremer, L. C. M.
Kuijpers, T. W.
Caron, H. N.
van de Wetering, M. D.
PEDIATRIC BLOOD & CANCER, 2011, 57 (01) : 89 - 96
[2] EFFECTS OF MANNOSE-BINDING LECTIN POLYMORPHISMS ON IRINOTECAN CHEMOTHERAPY-INDUCED FEBRILE NEUTROPENIA.
van der Bol, J. M.
de Jong, F. A.
van Schaik, R. H.
Sparreboom, A.
van de Geijn, F. E.
van Fessem, M. A.
Verweij, J.
Sleijfer, S.
Mathijssen, R. H.
CLINICAL PHARMACOLOGY & THERAPEUTICS, 2009, 85 : S8 - S8
[3] Effects of Mannose-Binding Lectin Polymorphisms on Irinotecan-Induced Febrile Neutropenia
van der Bol, Jessica M.
de Jong, Floris A.
van Schaik, Ron H.
Sparreboom, Alex
van Fessem, Marianne A.
de Geijn, Fleur E. van
van Daele, Paul L.
Verweij, Jaap
Sleijfer, Stefan
Mathijssen, Ron H.
ONCOLOGIST, 2010, 15 (10): : 1063 - 1072
[4] Maimose-binding lectin (MBL) serum level and genotype and risk of chemotherapy-induced febrile neutropenia (FN) in patients with solid tumors
Goudzwaard, J.
Fiets, W. Edward
van de Geijn, G. J.
Njo, T.
Zuetenhorst, J. M.
Birnle, E.
van Schalk, R. H. N.
van der Putten, M.
Polee, Marco
Hamberg, Paul
JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
[5] Relationship between mannose-binding lectin and febrile neutropenia in acute leukemia patients
Akan, Selcuk
Bakanay, Sule Mine
Bilen, Yusuf
Balcan, Baran
Erdem, Fuat
ANNALS OF CLINICAL AND ANALYTICAL MEDICINE, 2020, 11 (05): : 402 - 405
[6] The role of mannose-binding lectin (MBL) in paediatric oncology patients with febrile neutropenia
Frakking, F. N. J.
van de Wetering, M. D.
Brouwer, N.
Dolman, K. M.
Geissler, J.
Lemkes, B.
Caron, H. N.
Kuijpers, T. W.
EUROPEAN JOURNAL OF CANCER, 2006, 42 (07) : 909 - 916
[7] Risk and Consequences of Chemotherapy-Induced Febrile Neutropenia in Patients With Metastatic Solid Tumors
Weycker, Derek
Li, Xiaoyan
Edelsberg, John
Barron, Rich
Kartashov, Alex
Xu, Hairong
Lyman, Gary H.
JOURNAL OF ONCOLOGY PRACTICE, 2015, 11 (01) : 47 - +
[8] Risk factors of febrile neutropenia induced by chemotherapy in lung cancer patients
Tsuchida, Shinpei
Tsubouchi, Hironobu
Kitamura, Akiko
Matsumoto, Nobuhiro
Nakazato, Masamitsu
EUROPEAN RESPIRATORY JOURNAL, 2016, 48
[9] Pegfilgrastim for the prevention of chemotherapy-induced febrile neutropenia in patients with solid tumors
Lambertini, Matteo
Ferreira, Arlindo R.
Del Mastro, Lucia
Danesi, Romano
Pronzato, Paolo
EXPERT OPINION ON BIOLOGICAL THERAPY, 2015, 15 (12) : 1799 - 1817
[10] MANAGEMENT OF LOW RISK FEBRILE NEUTROPENIA IN SOLID TUMOR PATIENTS IN THE OUTPATIENT SETTING
Rodgers, Georgina
Tackitt, Helen
Kunapareddy, Girish
Stevenson, James
Colella, Frank
ONCOLOGY NURSING FORUM, 2018, 45 (02)

← 1 2 3 4 5 →